Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress Disorder

Summary

The primary aim of this pilot study is to test the efficacy of the selective serotonin re-uptake inhibitor, Escitalopram, in the treatment of posttraumatic stress disorder (PTSD) in an open clinical trial. A secondary aim is to determine whether treatment with escitalopram increases plasma allopregnanolone levels in patients with PTSD and if increases in allopregnanolone levels are correlated with treatment efficacy.

Timeline

Start

2003-02

Primary completion

2004-12

Completion

2004-12

Drugs

Indications